GlassScriptPhysician profile
Brian C Weiford
NPI 1144242538
$977.49
in general payments reported to CMS, 2019-2025
10 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.36 · 2020: $142 · 2021: $17.99 · 2022: $139 · 2023: $283 · 2024: $244 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $629.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $306.99 | 2022-2024 | Resolute Onyx |
| Boston Scientific Corporation | $231.40 | 2024-2025 | Watchman Flx |
| Medtronic Vascular, INC. | $124.72 | 2020 | |
| Amgen INC. | $93.72 | 2019-2022 | |
| Novo Nordisk INC | $56.08 | 2024 | Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $53.32 | 2020-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $45.95 | 2022 | |
| Sanofi-Aventis U.S. LLC | $39.25 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $15.16 | 2025 | Camzyos |
| Pfizer INC. | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Weiford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.